Cantor Fitzgerald maintains Overweight on Stratasys with $12 target

Published 11/02/2025, 13:52
© Stratasys PR

On Tuesday, Stratasys Inc. (NASDAQ:SSYS) stock maintained its Overweight rating with a steady price target of $12.00, as confirmed by Cantor Fitzgerald analysts. Trading near $12.06, InvestingPro data shows the stock has surged 67.5% over the past six months, despite analysts anticipating a sales decline this year. The firm’s analysis highlighted Stratasys’s projection of an increase in hardware revenue on a sequential basis, although it expects sales of consumables to be lower compared to the third quarter of 2024.

Stratasys, a leader in 3D printing technology with a market capitalization of $861 million, has provided financial outlooks for the year 2025. The company forecasts an adjusted EBITDA margin of 8% based on the current revenue levels of $578 million. Additionally, Stratasys anticipates that with moderate revenue growth, the adjusted EBITDA margin could reach approximately 10%. According to InvestingPro analysis, which offers 8 additional key insights about the company’s financial health, net income is expected to grow this year.

The company’s projections indicate a strategic focus on improving profitability while managing the various segments of its business. The emphasis on hardware revenue growth, despite the expected dip in consumables sales, suggests a balancing act between different revenue streams.

Stratasys’s guidance for the upcoming year reflects its confidence in the ongoing demand for its hardware products and its ability to adapt to market changes. The company’s performance in the next fiscal year will be closely watched by investors as it strives to meet these financial targets.

Investors and market watchers will continue to monitor Stratasys’s financial progress as the company navigates through the challenges and opportunities that lie ahead in the 3D printing industry. The reaffirmed Overweight rating and price target by Cantor Fitzgerald serve as a current evaluation of the company’s stock potential based on the latest projections and financial outlook.

In other recent news, Stratasys Direct, a Stratasys Ltd. facility in Tucson, Arizona, has achieved the internationally recognized ISO 13485 certification for medical device manufacturing. This development is expected to enhance the adoption of 3D-printed components in medical device manufacturing. In other developments, Cantor Fitzgerald analyst Troy Jensen reaffirmed an Overweight rating for Stratasys following a significant investment announcement from Fortissimo Capital. The investment is expected to boost Stratasys’s financial position and support its growth endeavors.

Stratasys also reported a preliminary adjusted net income for the fourth quarter that exceeded the Bloomberg consensus estimate. The company anticipates delivering meaningful positive cash flow from operating activities for the full year 2025. Stratasys has also secured an exclusive role as NASCAR’s sole 3D printing partner, aiming to enhance NASCAR’s design and manufacturing processes for parts and tools. Lastly, Stratasys extended its partnership with Joe Gibbs Racing (JGR), further integrating its 3D printing solutions into high-performance racing. These are among the recent developments involving Stratasys.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.